Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|November 19, 2025
Synthesis of Novel PARP Inhibitors and Their Uses in Treatment of PARPs Related DiseasesXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel 2<i>H</i>‑Pyrazolo[3,4‑<i>d</i>]thiazole Compounds Targeting NLRP3 for the Treatment of Neurodegenerative DiseasesZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Spiro-Ureas as Monoacylglycerol Lipase InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Substituted Benzisoxazole Sulfonamides as Lysine Acetyl Transferase Inhibitors for the Treatment of CancersJian Rong, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementiasTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Development of Bicyclic Compounds Containing a Tertiary Amine Moiety as T Cell ActivatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Indazole Propionic Acid Derivatives as AMPK ActivatorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Novel Isoindolin-1-one Derivatives as Metabotropic Glutamate Receptor Positive Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Targeted Treatment of Cancer by Using Conjugate Compounds with Poly(ADP-ribose) Polymerase (PARP) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Heterocyclic Piperazine Amide Derivatives as Alpha-synuclein PET Ligands for Diagnosis of Parkinson's DiseaseYinlong Li, Steven H Liang
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|November 19, 2025
Synthesis of Novel PARP Inhibitors and Their Uses in Treatment of PARPs Related DiseasesXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel 2<i>H</i>‑Pyrazolo[3,4‑<i>d</i>]thiazole Compounds Targeting NLRP3 for the Treatment of Neurodegenerative DiseasesZhendong Song, Steven H Liang
ACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Spiro-Ureas as Monoacylglycerol Lipase InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|February 18, 2026
Novel Substituted Benzisoxazole Sulfonamides as Lysine Acetyl Transferase Inhibitors for the Treatment of CancersJian Rong, Steven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementiasTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Development of Bicyclic Compounds Containing a Tertiary Amine Moiety as T Cell ActivatorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Indazole Propionic Acid Derivatives as AMPK ActivatorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Novel Isoindolin-1-one Derivatives as Metabotropic Glutamate Receptor Positive Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|July 16, 2025
Targeted Treatment of Cancer by Using Conjugate Compounds with Poly(ADP-ribose) Polymerase (PARP) InhibitorsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Heterocyclic Piperazine Amide Derivatives as Alpha-synuclein PET Ligands for Diagnosis of Parkinson's DiseaseYinlong Li, Steven H Liang
Pageof 27